Table 1.
Group | Drug Treatment | Sample Delay | Hematuria Score | GCH % | Fibrin % | BSW w/o GCH μm | BSW w/GCH μm |
---|---|---|---|---|---|---|---|
Exposed | none | 5 min | nd | 61.0 ± 17.5 | nd | 8.7 ± 2.2 | 15.6 ± 6.0 |
Exposed | none | 30 min | nd | 68.7 ± 23.0 | nd | 9.2 ± 3.6 | 15.6 ± 6.9 |
Sham | none | 4 h | 0.6 ± 0.5 | 0 | 0 | 7.1 ± 2.1 | nd |
Exposed | none | 4 h | 50 ± 23 | 36.3 ± 14.3 | 46.8 ± 13.3 | 8.9 ± 3.3 | 14.0 ± 6.5 |
Exposed | none | 2 d | 56 ± 31 | 0 | 11.8 ± 4.8 | 9.2 ± 2.8 | nd |
Sham | heparin | 4 h | 2.6 ± 3.0 | 0 | 0 | 7.4 ± 1.8 | nd |
Exposed | heparin | 4 h | 53 ± 18 | 15.0 ± 7.7 | 32.0 ± 11.3 | 9.0 ± 3.4 | 15.6 ± 5.2 |
Sham | ACA | 4 h | 2.0 ± 1.7 | 0 | 0 | 7.9 ± 2.1 | nd |
Exposed | ACA | 4 h | 52 ± 15 | 63.7 ±10.7 | 67.8 ± 22.0 | 9.0 ± 2.3 | 14.3 ± 5.5 |